(Q42537156)

1 November 2017

Pyrroles and other heterocycles as inhibitors of p38 kinase (English)

1 reference

1 November 2017

de Laszlo SE

1

1 reference

1 November 2017

Visco D

2

1 reference

1 November 2017

Agarwal L

3

1 reference

1 November 2017

Chang L

4

1 reference

1 November 2017

Chin J

5

1 reference

1 November 2017

Croft G

6

1 reference

1 November 2017

Forsyth A

7

1 reference

1 November 2017

Fletcher D

8

1 reference

1 November 2017

Frantz B

9

1 reference

1 November 2017

Hacker C

10

1 reference

1 November 2017

Hanlon W

11

1 reference

1 November 2017

Harper C

12

1 reference

1 November 2017

Kostura M

13

1 reference

1 November 2017

Li B

14

1 reference

1 November 2017

Luell S

15

1 reference

1 November 2017

MacCoss M

16

1 reference

1 November 2017

Mantlo N

17

1 reference

1 November 2017

O'Neill EA

18

1 reference

1 November 2017

Orevillo C

19

1 reference

1 November 2017

Pang M

20

1 reference

1 November 2017

Parsons J

21

1 reference

1 November 2017

Rolando A

22

1 reference

1 November 2017

Sahly Y

23

1 reference

1 November 2017

Sidler K

24

1 reference

1 November 2017

O'Keefe SJ

25

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

Bioorganic & Medicinal Chemistry Letters

1 November 2017

1 reference

1 November 2017

8

1 reference

1 November 2017

2689-2694

1 reference

1 November 2017

19

1 reference

Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900495-8

7 January 2021

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900495-8

7 January 2021

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900495-8

7 January 2021

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900495-8

7 January 2021

A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900495-8

7 January 2021

A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900495-8

7 January 2021

1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900495-8

7 January 2021

Kinetic mechanism for p38 MAP kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900495-8

7 January 2021

Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900495-8

7 January 2021

p38-2, a novel mitogen-activated protein kinase with distinct properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900495-8

7 January 2021

Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900495-8

7 January 2021

10.1016/S0960-894X(98)00495-8

Identifiers

DOI

1 reference

1 November 2017

1 reference